Laura E. Kilpatrick

1.9k total citations · 1 hit paper
42 papers, 1.3k citations indexed

About

Laura E. Kilpatrick is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Laura E. Kilpatrick has authored 42 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 16 papers in Cellular and Molecular Neuroscience and 10 papers in Oncology. Recurrent topics in Laura E. Kilpatrick's work include Receptor Mechanisms and Signaling (22 papers), Neuropeptides and Animal Physiology (13 papers) and Angiogenesis and VEGF in Cancer (9 papers). Laura E. Kilpatrick is often cited by papers focused on Receptor Mechanisms and Signaling (22 papers), Neuropeptides and Animal Physiology (13 papers) and Angiogenesis and VEGF in Cancer (9 papers). Laura E. Kilpatrick collaborates with scholars based in United Kingdom, United States and Australia. Laura E. Kilpatrick's co-authors include Stephen J. Hill, Stephen J. Briddon, Leigh A. Stoddart, Jeanette Woolard, Chloe J. Peach, Diana C. Alcobia, Maria Augusta Arruda, Nicholas D. Holliday, Açelya Yılmazer and Andrew M. Jackson and has published in prestigious journals such as Nature Communications, Annual Review of Biochemistry and The FASEB Journal.

In The Last Decade

Laura E. Kilpatrick

41 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Molecular Pharmacology of VEGF-A Isoforms: Binding and Signalling at VEGFR2

2018 366 citations Chloe J. Peach, Maria Augusta Arruda et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Laura E. Kilpatrick United Kingdom	17	871	294	287	258	138	42	1.3k
Hiroko Iwanari Japan	18	949 1.1×	251 0.9×	221 0.8×	271 1.1×	129 0.9×	31	1.7k
Xiaozhong Qian United States	17	1.3k 1.5×	260 0.9×	627 2.2×	211 0.8×	54 0.4×	37	2.0k
Jeanette Woolard United Kingdom	20	1.4k 1.6×	244 0.8×	318 1.1×	126 0.5×	205 1.5×	50	2.0k
Tom S. Wehrman United States	18	1.1k 1.3×	543 1.8×	276 1.0×	222 0.9×	185 1.3×	27	1.5k
Peishen Zhao Australia	21	1.2k 1.4×	632 2.1×	172 0.6×	143 0.6×	109 0.8×	49	2.0k
Rink‐Jan Lohman Australia	22	715 0.8×	150 0.5×	130 0.5×	158 0.6×	50 0.4×	37	1.4k
Paul Fischer United States	27	1.1k 1.3×	171 0.6×	544 1.9×	1.1k 4.3×	134 1.0×	55	2.8k
Alejandra Tomás United Kingdom	27	1.5k 1.8×	322 1.1×	233 0.8×	129 0.5×	103 0.7×	61	2.4k
Manju Swaroop United States	27	1.5k 1.7×	405 1.4×	320 1.1×	132 0.5×	42 0.3×	42	2.6k
Emmanuel Normant United States	22	1.3k 1.5×	131 0.4×	370 1.3×	235 0.9×	42 0.3×	50	2.0k

Countries citing papers authored by Laura E. Kilpatrick

Since Specialization

Citations

This map shows the geographic impact of Laura E. Kilpatrick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura E. Kilpatrick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura E. Kilpatrick more than expected).

Fields of papers citing papers by Laura E. Kilpatrick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura E. Kilpatrick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura E. Kilpatrick. The network helps show where Laura E. Kilpatrick may publish in the future.

Co-authorship network of co-authors of Laura E. Kilpatrick

This figure shows the co-authorship network connecting the top 25 collaborators of Laura E. Kilpatrick. A scholar is included among the top collaborators of Laura E. Kilpatrick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura E. Kilpatrick. Laura E. Kilpatrick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Arruda, Maria Augusta, Laura E. Kilpatrick, Benjamin Moore, et al.. (2025). Quantitative analysis of human umbilical vein endothelial cell morphology and tubulogenesis. Journal of Microscopy. 300(2). 234–249. 1 indexed citations

White, Carl W., Laura E. Kilpatrick, Nicholas D. Kindon, et al.. (2024). CXCL17 is an allosteric inhibitor of CXCR4 through a mechanism of action involving glycosaminoglycans. Science Signaling. 17(828). eabl3758–eabl3758. 10 indexed citations

Soave, Mark, et al.. (2024). Mechano-sensitivity of β2-adrenoceptors enhances constitutive activation of cAMP generation that is inhibited by inverse agonists. Communications Biology. 7(1). 417–417.

Goulding, Joëlle, Marleen Groenen, Jeanette Woolard, et al.. (2024). Ligand-Directed Labeling of the Adenosine A₁ Receptor in Living Cells. Journal of Medicinal Chemistry. 67(14). 12099–12117. 2 indexed citations

Kilpatrick, Laura E., et al.. (2024). Design, Synthesis, and Evaluation of a New Chemotype Fluorescent Ligand for the P2Y₂ Receptor. ACS Medicinal Chemistry Letters. 15(7). 1127–1135. 2 indexed citations

Goulding, Joëlle, Nicholas D. Kindon, Laura E. Kilpatrick, et al.. (2023). Small-Molecule Fluorescent Ligands for the CXCR4 Chemokine Receptor. Journal of Medicinal Chemistry. 66(7). 5208–5222. 7 indexed citations

Isidro‐Llobet, Albert, et al.. (2023). Characterisation of IL-23 receptor antagonists and disease relevant mutants using fluorescent probes. Nature Communications. 14(1). 2882–2882. 4 indexed citations

Arimont, Marta, Meritxell Canals, Chris de Graaf, et al.. (2023). Small Molecule Fluorescent Ligands for the Atypical Chemokine Receptor 3 (ACKR3). ACS Medicinal Chemistry Letters. 15(1). 143–148. 3 indexed citations

Kilpatrick, Laura E., et al.. (2023). Characterisation of tyrosine kinase inhibitor-receptor interactions at VEGFR2 using sunitinib-red and nanoBRET. Biochemical Pharmacology. 214. 115672–115672. 2 indexed citations

10.

Hill, Stephen J. & Laura E. Kilpatrick. (2023). Kinetic analysis of fluorescent ligand binding to cell surface receptors: Insights into conformational changes and allosterism in living cells. British Journal of Pharmacology. 181(21). 4091–4102. 6 indexed citations

11.

Kilpatrick, Laura E., et al.. (2022). Use of NanoBiT and NanoBRET to characterise interleukin‐23 receptor dimer formation in living cells. British Journal of Pharmacology. 180(11). 1444–1459. 3 indexed citations

12.

Stoddart, Leigh A., Laura E. Kilpatrick, Ross Corriden, et al.. (2021). Efficient G protein coupling is not required for agonist‐mediated internalization and membrane reorganization of the adenosine A ₃ receptor. The FASEB Journal. 35(4). e21211–e21211. 3 indexed citations

13.

Peach, Chloe J., Laura E. Kilpatrick, Jeanette Woolard, & Stephen J. Hill. (2021). Use of NanoBiT and NanoBRET to monitor fluorescent VEGF‐A binding kinetics to VEGFR2/NRP1 heteromeric complexes in living cells. British Journal of Pharmacology. 178(12). 2393–2411. 14 indexed citations

14.

Kilpatrick, Laura E. & Stephen J. Hill. (2021). The use of fluorescence correlation spectroscopy to characterise the molecular mobility of G protein-coupled receptors in membrane microdomains: an update. Biochemical Society Transactions. 49(4). 1547–1554. 5 indexed citations

15.

Kilpatrick, Laura E. & Stephen J. Hill. (2020). Transactivation of G protein-coupled receptors (GPCRs) and receptor tyrosine kinases (RTKs): Recent insights using luminescence and fluorescence technologies. Current Opinion in Endocrine and Metabolic Research. 16. 102–112. 59 indexed citations

16.

Sykes, David A., Leigh A. Stoddart, Laura E. Kilpatrick, & Stephen J. Hill. (2019). Binding kinetics of ligands acting at GPCRs. Molecular and Cellular Endocrinology. 485. 9–19. 73 indexed citations

17.

Kindon, Nicholas D., Mark Soave, Leigh A. Stoddart, et al.. (2019). Subtype-Selective Fluorescent Ligands as Pharmacological Research Tools for the Human Adenosine A_2A Receptor. Journal of Medicinal Chemistry. 63(5). 2656–2672. 25 indexed citations

18.

Kilpatrick, Laura E., Diana C. Alcobia, Carl W. White, et al.. (2019). Complex Formation between VEGFR2 and the β2-Adrenoceptor. Cell chemical biology. 26(6). 830–841.e9. 28 indexed citations

19.

Peach, Chloe J., Laura E. Kilpatrick, Jeanette Woolard, & Stephen J. Hill. (2019). Comparison of the ligand‐binding properties of fluorescent VEGF‐A isoforms to VEGF receptor 2 in living cells and membrane preparations using NanoBRET. British Journal of Pharmacology. 176(17). 3220–3235. 9 indexed citations

20.

Peach, Chloe J., Laura E. Kilpatrick, Kris Zimmerman, et al.. (2018). Real-Time Ligand Binding of Fluorescent VEGF-A Isoforms that Discriminate between VEGFR2 and NRP1 in Living Cells. Cell chemical biology. 25(10). 1208–1218.e5. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact